Quality-by-Design-Based Development of Hyaluronic Acid-Conjugated Gemcitabine-Loaded PLGA Nanoparticles for Targeted Anticancer Drug Delivery

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{205286,
        author = {MAHEFUZABIBI ARAF and Dr. Ronak Dedania},
        title = {Quality-by-Design-Based Development of Hyaluronic Acid-Conjugated Gemcitabine-Loaded PLGA Nanoparticles for Targeted Anticancer Drug Delivery},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {13},
        number = {1},
        pages = {5714-5729},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=205286},
        abstract = {},
        keywords = {Gemcitabine; PLGA nanoparticles; Hyaluronic acid; Targeted drug delivery; Quality by Design; Controlled release; Anticancer therapy},
        month = {June},
        }

Cite This Article

ARAF, M., & Dedania, D. R. (2026). Quality-by-Design-Based Development of Hyaluronic Acid-Conjugated Gemcitabine-Loaded PLGA Nanoparticles for Targeted Anticancer Drug Delivery. International Journal of Innovative Research in Technology (IJIRT), 13(1), 5714–5729.

Related Articles